OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Repligen Corp/  US7599161095  /

IEX
2024-07-26  9:59:57 PM Chg. +8.63 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
140.94USD +6.52% 92,342
Turnover: 12.93 mill.		 -Bid Size: - -Ask Size: - 7.87 bill.USD - 187.72
GlobeNewswire 06-13 Repligen Announces CEO Transition Plan
GlobeNewswire 05-22 Repligen Corporation to Present at Upcoming June Investor Conferences
GlobeNewswire 05-07 Repligen Corporation to Present at Upcoming May Investor Conferences
GlobeNewswire 05-06 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 05-01 Repligen Reports First Quarter 2024 Financial Results
GlobeNewswire 04-17 Repligen to Report First Quarter 2024 Financial Results
GlobeNewswire 03-19 Repligen Appoints Maggie A. Pax to Board of Directors
GlobeNewswire 02-21 Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 2023-12-19 Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 2023-12-07 Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convert...
GlobeNewswire 2023-11-14 UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report
GlobeNewswire 2023-11-14 Repligen Announces Publication of the Company’s 2022 Sustainability Report
GlobeNewswire 2023-11-07 Repligen Corporation to Present at Upcoming Investor Conferences
GlobeNewswire 2023-11-02 Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device
GlobeNewswire 2023-10-31 Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
GlobeNewswire 2023-10-17 Repligen to Report Third Quarter 2023 Financial Results
GlobeNewswire 2023-10-10 Jonathan Milner issues Open Letter to shareholders of Abcam plc
GlobeNewswire 2023-10-02 Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire 2023-09-26 Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova
GlobeNewswire 2023-09-12 Repligen Appoints Jason K. Garland as Chief Financial Officer
GlobeNewswire 2023-09-01 Repligen Corporation to Present at Wells Fargo Healthcare Conference
GlobeNewswire 2023-08-17 Sartorius and Repligen Corporation Launch Integrated System with Biostat STR® and XCell® ATF for Ups...
GlobeNewswire 2022-03-18 Repligen Corporation to Present at KeyBanc Life Science and MedTech Investor Forum
GlobeNewswire 2022-02-17 Repligen Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire 2022-02-15 Repligen Launches AAV Affinity Resins for Gene Therapy Purification